The paradox of ventilator-associated pneumonia prevention measures.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 2784360)

Published in Crit Care on October 15, 2009

Authors

Michael Klompas1

Author Affiliations

1: Infection Control Department, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. mklompas@partners.org

Articles cited by this

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med (2000) 11.54

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet (2008) 10.13

Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88

Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med (1996) 6.79

Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet (1999) 6.38

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13

Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med (2006) 5.35

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med (1993) 4.28

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med (2000) 4.21

A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med (1995) 4.18

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83

Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA (1996) 3.21

Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA (2006) 3.09

Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA (2008) 3.01

Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest (2008) 2.78

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med (1999) 2.69

Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med (2005) 2.67

Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med (2006) 2.60

Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax (1999) 2.47

Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med (2004) 2.46

A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med (2006) 2.45

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med (1994) 2.45

Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ (2007) 2.44

Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med (2005) 2.37

Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med (2001) 2.35

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest (2004) 2.26

A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest (2002) 2.22

A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med (1997) 2.18

Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest (1996) 2.14

Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med (1995) 2.14

Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2008) 2.07

Does this patient have ventilator-associated pneumonia? JAMA (2007) 2.03

Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med (1995) 2.01

Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med (2001) 1.95

Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect (Larchmt) (2001) 1.93

Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest (2006) 1.84

Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81

A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest (1999) 1.77

Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med (1994) 1.74

Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care (2002) 1.72

Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest (1994) 1.71

Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest (2000) 1.56

Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med (2000) 1.53

Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med (2007) 1.52

Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med (2000) 1.51

The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest (1997) 1.49

Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med (1996) 1.47

Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med (1996) 1.46

Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med (1995) 1.42

Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med (1996) 1.17

Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med (1992) 1.17

Ventilator-associated pneumonia--the wrong quality measure for benchmarking. Ann Intern Med (2007) 1.16

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology (2004) 1.13

Eliminating nosocomial infections at Ascension Health. Jt Comm J Qual Patient Saf (2006) 1.12

An evaluation of the impact of the ventilator care bundle. Nurs Crit Care (2005) 1.07

The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Respir Crit Care Med (1995) 1.04

Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med (2009) 0.95

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med (2005) 0.87

Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care (2002) 0.85

Efficacy of a pneumonia prevention protocol in the reduction of ventilator-associated pneumonia in trauma patients. Surg Infect (Larchmt) (2007) 0.85

Oropharyngeal decontamination with gentamicin for long-term ventilated patients on stress ulcer prophylaxis with sucralfate? Wien Klin Wochenschr (1994) 0.82

"Ventilator bundle" approach to prevention of ventilator-associated pneumonia. Mayo Clin Proc (2006) 0.80

Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study. Eur J Clin Pharmacol (2005) 0.79